Time to reconsider guidelines on clarithromycin in chronic rhinosinusitis?

BMJ. 2013 May 1:346:f2678. doi: 10.1136/bmj.f2678.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Acute Coronary Syndrome / chemically induced*
  • Anti-Bacterial Agents / adverse effects*
  • Clarithromycin / adverse effects*
  • Female
  • Humans
  • Male
  • Pneumonia / drug therapy*

Substances

  • Anti-Bacterial Agents
  • Clarithromycin